Trinity Biotech PLC (TRIB)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -32.816 | -18.198 | -12.819 | -20.453 | -4.886 | 0.702 | -38.871 | -31.699 |
Return on Equity (%) | -62.38 | -46.308 | -40.439 | -118.58 | -512.269 | -68.952 | 3287.295 | 183.87 |
Return on Invested Capital (%) | 3.494 | 0.551 | 5.917 | 2.434 | 15.343 | 26.549 | -26.54 | -33.641 |
Operating Margin (%) | -99.31 | -36.392 | -18.679 | -25.806 | 0.116 | 8.442 | -21.997 | -21.846 |
Net Profit Margin (%) | -101.018 | -40.619 | -22.765 | -31.972 | -6.264 | 0.941 | -54.84 | -40.288 |
Book Value Per Share | 0.223 | 0.005 | -0.093 | -0.405 | -0.375 | -0.377 | -0.389 | -0.244 |
Earnings Per Share | -1.046 | -0.419 | -0.23 | -0.301 | -0.066 | 0.009 | -0.426 | -0.146 |
Cash Per Share | 0.802 | 0.245 | 0.315 | 0.158 | 0.284 | 0.269 | 0.068 | 0.022 |
Working Capital Per Share | 1.125 | 0.95 | 0.718 | 0.54 | 0.585 | -0.289 | 0.305 | 0.146 |
Operating Profit Per Share | 0.515 | 0.491 | 0.475 | 0.448 | 0.525 | 0.473 | 0.257 | 0.146 |
EBIT Per Share | -1.085 | -0.431 | -0.241 | -0.311 | -0.069 | 0.008 | -0.428 | -0.146 |
EBITDA Per Share | -1.085 | -0.431 | -0.241 | -0.311 | -0.069 | 0.008 | -0.428 | -0.146 |
Free Cash Flow Per Share | -0.899 | -0.322 | -0.093 | -0.228 | 0.039 | 0.071 | -0.389 | -0.14 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -25.389 | N/A | N/A | N/A | -20.307 | N/A |
Net Profit Margin (%) | N/A | N/A | -39.173 | N/A | N/A | N/A | -22.558 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 10.79M |
Price to Earnings Ratio | 0 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 9.47M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.